Directory › PolyPeptide

PolyPeptide — Braine-L'Alleud

Braine-L'Alleud, Belgium · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
PolyPeptide
Name(s) in FDA data
PolyPeptide SA
FEI number(s)
3002808410 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Braine-L'Alleud, Belgium
Records matched
6 FDA inspections
Most recent FDA inspection in dataset
18 Dec 2023 — VAI

Capabilities (from the company's website)

  • Peptides & oligonucleotides
    …PolyPeptide in Braine-l’Alleud, Belgium The latest acquisition of the peptide manufacturing facility…
  • Spray drying & particle engineering
    …6,300L), and large scale purification & isolation capabilities including industrial scale spray drying for peptide drug substances. The facility has also been inspected by the Federal Agen…

Taken from the company's web page for this site. Source: https://www.polypeptide.com/contacts/manufacturing-sites/braine-lalleud-belgium/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 18 Dec 2023
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808410, inspection ID 1312276)

  2. 02 Oct 2020
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808410, inspection ID 1178037)

  3. 16 Mar 2017
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808410, inspection ID 1017697)

  4. 30 May 2014
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808410, inspection ID 880413)

  5. 14 Jun 2012
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808410, inspection ID 792099)

  6. 16 Jun 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002808410, inspection ID 592340)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.